INDV

Indivior Pharmaceuticals Inc · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-02-26

Figures on this page computed 2026-11-08 12:32 UTC

Last close

36.28USD

Market data, 2026-11-02

Except where said otherwise: 10-K for 2025, filed 2026-02-26

  • 21.6xP/E

    Price / Earnings per Share (diluted)

    Source
    computed
    Fiscal year
    2025
    Accession
    0001628280-26-012237
    Reported in
    USD
    • computed
    • 10-K for 2025, filed 2026-02-26

    The filing itself

  • 396.9%ROIC

    NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash

    Source
    computed
    Fiscal year
    2025
    Accession
    0001628280-26-012237
    Reported in
    USD
    • 10-K for 2025, filed 2026-02-26
    • 10-K for 2025, filed 2026-02-26
    • 10-K for 2025, filed 2026-02-26
    • 10-Q for 2025, filed 2026-10-29
    • 10-K for 2025, filed 2026-02-26
    • 10-Q for 2025, filed 2026-10-29

    The filing itself

  • 16.9%Net margin

    Net Income / Revenue x 100

    Source
    computed
    Fiscal year
    2025
    Accession
    0001628280-26-012237
    Reported in
    USD
    • 10-K for 2025, filed 2026-02-26
    • 10-K for 2025, filed 2026-02-26

    The filing itself

  • -7.5%FCF margin

    Free Cash Flow / Revenue x 100

    Source
    computed
    Fiscal year
    2025
    Accession
    0001628280-26-012237
    Reported in
    USD
    • 10-K for 2025, filed 2026-02-26
    • 10-K for 2025, filed 2026-02-26

    The filing itself

  • n/aDebt/equity

    We do not hold this figure for this company, so there is nothing to place.

    Total Debt / Shareholders' Equity

    Source
    computed
    Fiscal year
    2025
    Accession
    0001628280-26-012237
    Reported in
    USD
    • 10-K for 2025, filed 2026-02-26
    • 10-Q for 2025, filed 2026-10-29

    The filing itself

  • n/aDividend yield

    The stored value is a zero that stands for missing data rather than a measurement, so we will not place it.

    Source
    computed
    Taken on
    2026-11-07
    Reported in
    USD
    • computed
    • Computed from the filing for 2016

What it sells, to whom

lens 8 of 9

What it sells

1
Reportable Segment1,239,000,000 USD100%

Where it sells it

1
UNITED STATES3,000,000 USD100%

Each band is a share of itself. A segment and a place are two cuts of the same revenue, so they are never added together.

1 segments, 1 places and 0 named customers, each as the filer published it.

1 segments, 1 places and 0 named customers, each as the filer published it.

Every figure in this lens

  • Reportable Segment1,239,000,00010-K for 2025, filed 2026-02-26
    Source
    filed
    Statement
    segments
    Fiscal year
    2025
    Accession
    0001628280-26-012237
    Reported in
    USD

    The filing itself

  • UNITED STATES3,000,00010-K for 2024, filed 2025-03-03
    Source
    filed
    Statement
    revenue_mix
    Fiscal year
    2024
    Accession
    0001625297-25-000016
    Reported in
    USD

    The filing itself

Filed figures cite the filing they come from; figures marked Market data are quotes as of the date shown. Not a recommendation and not advice.

Past figures are not a forecast. Anything we modelled is labelled as ours. You can lose money on any security.